Preferred Label : Aurora A Kinase Inhibitor MK5108;
NCIt related terms : MK-5108;
NCIt definition : An orally bioavailable, highly selective small molecule inhibitor of the serine/threonine
protein kinase Aurora A, with potential antimitotic and antineoplastic activity. Aurora
A kinase inhibitor MK5108 binds to and inhibits Aurora A kinase, which may result
in disruption of the assembly of the mitotic spindle apparatus, disruption of chromosome
segregation, and eventually inhibition of cell division, proliferation and an induction
of apoptosis in cells overexpressing Aurora A kinase. Aurora A kinase localizes to
the spindle poles and to spindle microtubules during mitosis, and is thought to regulate
spindle assembly. Aurora kinases are overexpressed in a wide variety of cancers.;
UNII : H8J407531S;
InChIKey : LCVIRAZGMYMNNT-VVONHTQRSA-N;
CAS number : 1010085-13-8; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1010085-13-8
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;